Global Oral Insulin Market: Size and Forecast with Impact Analysis of COVID-19 (2021-2025)

The study covers research analysis on Global Oral Insulin Market which provides present market dynamics, key statistics and key player’s analysis.

Dallas, United States - July 15, 2021 /MarketersMedia/

Scope of the Report

The report titled Global Oral Insulin Market: Size & Forecast with Impact Analysis of COVID-19 (2021-2025), provides an in depth analysis of the global oral insulin market by value, by region, etc. The report provides a regional analysis of the oral insulin market, including the following regions: North America (The US, Mexico, and Canada); Europe (Germany, UK, France, Italy, Spain, and Rest of Europe); Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific); and ROW (Brazil, Saudi Arabia, South Africa, and ROW Countries). The report also provides a detailed analysis of the COVID-19 impact on the oral insulin market.

The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global oral insulin market has also been forecasted for the period 2021-2025, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

The global oral insulin market is consolidated with few major market players operating worldwide. The key players of the oral insulin market are Novo Nordisk A/S, Oramed Pharmaceuticals Inc., vTv Therapeutics, and Diabetology Ltd. are also profiled with their financial information and respective business strategies.

Country Coverage

North America
Europe
Asia Pacific
Rest of World

Company Coverage

Novo Nordisk A/S
Oramed Pharmaceuticals Inc.
vTv Therapeutics
Diabetology Ltd.

? Executive Summary

The oral delivery of drugs is considered as the most acceptable and convenient route of drug administration especially for chronic diseased conditions like diabetes. The treatment with oral insulin offers several advantages, such as higher patient compliance; rapid hepatic insulinization, and avoidance of peripheral hyperinsulinemia and other adverse effects such as possible hypoglycemia and weight gain.

The oral insulin market can be segmented on the basis of application (Type 1 diabetes and Type 2 diabetes); and gender (Female and Male).

The global oral insulin market has increased significantly during the years 2019-2020 and projections are made that the market would rise in the next four years i.e. 2021-2025 tremendously. The oral insulin market is expected to increase due to rapid urbanization, escalating healthcare spending, increasing prevalence of diabetes, favorable government initiatives, advantages of oral insulin over injectable insulin, etc. Yet the market faces some challenges such as uncertainty around getting the FDA approval, low oral bioavailability, etc.

ABOUT US:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

CONTACT US:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (972)-362-8199; +91 895 659 5155

Contact Info:
Name: Hector Costello
Email: Send Email
Organization: Orbis Research
Address: 4144N Central Expressway, Suite 600
Phone: +1 (972)-362-8199
Website: https://www.orbisresearch.com

Source URL: https://marketersmedia.com/global-oral-insulin-market-size-and-forecast-with-impact-analysis-of-covid-19-2021-2025/89036420

Source: MarketersMedia

Release ID: 89036420

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.